Symptoms after breast cancer treatment: are they influenced by patient characteristics? Jean YoonJennifer L. MalinKatherine L. Kahn Review 10 May 2007 Pages: 153 - 165
Breast cancer risk in women with radial scars in benign breast biopsies Jena C. BergDaniel W. VisscherLynn C. Hartmann Review 22 May 2007 Pages: 167 - 174
Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion M. SmollichM. GötteP. Wülfing Preclinical Study 28 April 2007 Pages: 175 - 182
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer Fabrice AndreChafika MazouniLajos Pusztai Preclinical Study 28 April 2007 Pages: 183 - 190
Predicting features of breast cancer with gene expression patterns Xuesong LuXin LuAndrea L. Richardson Preclinical Study 22 May 2007 Pages: 191 - 201
Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells Zilal KattanVanessa MinigPhilippe Becuwe Preclinical Study 02 May 2007 Pages: 203 - 215
Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women Anne McTiernanLieLing WuFor the WHI Investigators Clinical Trial 22 May 2007 Pages: 217 - 231
Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients Jenny C. ChangAndreas MakrisSteven Shak Clinical Trial 28 April 2007 Pages: 233 - 240
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Keun Seok LeeHyun Cheol ChungJungsil Ro Clinical Trial 03 May 2007 Pages: 241 - 250
Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients Ragne K. FarmenOddmund NordgårdReino Heikkilä Clinical Trial 10 May 2007 Pages: 251 - 258
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis Dino AmadoriOriana NanniRosella Silvestrini Clinical Trial 26 May 2007 Pages: 259 - 264
Decision making in adjuvant trials in breast cancer: the NCIC CTG MA.17 trial as an example Joseph PaterDongsheng TuPaul E. Goss Clinical Trial 03 May 2007 Pages: 265 - 269
Fiberoptic ductoscopy combined with cytology testing in the patients of spontaneous nipple discharge Guang-Yu LiuJing-Song LuZhi-Min Shao Clinical Trial 02 May 2007 Pages: 271 - 277
Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial Helen M. MilneKaren E. WallmanKerry S. Courneya Clinical Study 26 May 2007 Pages: 279 - 288
Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers T. ByrskiJ. Gronwaldthe Polish Hereditary Breast Cancer Consortium Epidemiology 10 May 2007 Pages: 289 - 296
Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis Elise M. PelletierBoyung ShimMayur M. Amonkar Epidemiology 19 June 2007 Pages: 297 - 305